Why the study?
Does cardiopulmonary exercise testing provide prognostic value and assess functional capacity in patients with cardiac amyloidosis?
Does cardiopulmonary exercise testing provide prognostic value and assess functional capacity in patients with cardiac amyloidosis?
Cardiopulmonary exercise testing provides valuable prognostic and functional information in patients with cardiac amyloidosis.
May support CPET for functional and prognostic assessment in amyloidosis; leaves open prospective validation before routine adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nicol et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: